secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001104659-23-088604
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Rhythm Pharma terminates CAO, appoints Christopher German as principal accounting officer
--------------------------------------------------------------------------------

- William T. Roberts terminated as CAO effective Aug 11, 2023; no reason stated.
- Christopher German, Executive Director, Corporate Controller since Mar 2023, named principal accounting officer.
- German brings 20+ years experience in financial reporting and accounting; holds CPA and B.S. from Lehigh.
- German previously served as Corporate Controller at Oncorus (2021-2023) and Repligen (2018-2021).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000110465923088604/0001104659-23-088604-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000110465923088604/tm2323116d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-088604

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer